Trends in drug resistance-associated mutations in a real-life cohort of Italian patients infected with HIV-1-Reference-Cited by-同舟云学术

Trends in drug resistance-associated mutations in a real-life cohort of Italian patients infected with HIV-1

Published:2015-12 Issue:4 Volume:3 Page:267-272
ISSN:2213-7165
Container-title:Journal of Global Antimicrobial Resistance
language:en
Short-container-title:Journal of Global Antimicrobial Resistance

Author:

Montagna Claudia,Mazzuti Laura,Falasca Francesca,Maida Paola,Bucci Mauro,D’Ettorre Gabriella,Mezzaroma Ivano,Fantauzzi Alessandra,Alvaro Nadia,Vullo Vincenzo,Antonelli Guido,Turriziani Ombretta

Publisher

Elsevier BV

Subject

Microbiology (medical),Immunology,Immunology and Allergy,Microbiology

Reference30 articles.

1. Increased resilience to the development of drug resistance with modern boosted protease inhibitor-based highly active antiretroviral therapy;Lima;J Infect Dis,2008

2. Nine-year trends in clinically relevant reduced susceptibility of HIV-1 to antiretrovirals;Sista;J Clin Virol,2009

3. The incidence rate of HIV type-1 drug resistance in patients on antiretroviral therapy: a nationwide population-based Danish cohort study 1999–2005;Audelin;Antivir Ther,2009

4. Evolution of human immunodeficiency virus type 1 (HIV-1) resistance mutations in nonnucleoside reverse transcriptase inhibitors (NNRTIs) in HIV-1-infected patients switched to antiretroviral therapy without NNRTIs;Joly;Antimicrob Agents Chemother,2004

5. Trends in antiretroviral therapy and prevalence of HIV drug resistance mutations in Sweden 1997–2011;Bontell;PLOS ONE,2013

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reduced probability of improving viro‐immunological state in subjects with vertical transmission of HIV reaching adult age: A multicenter retrospective cohort study;Immunity, Inflammation and Disease;2023-02

2. Transmitted drug resistance mutations and trends of HIV-1 subtypes in treatment-naïve patients: A single-centre experience;Journal of Global Antimicrobial Resistance;2020-03

3. Dolutegravir (DTG)-containing regimens after receiving raltegravir (RAL) or elvitegravir (EVG): Durability and virological response in a large Italian HIV drug resistance network (ARCA);Journal of Clinical Virology;2018-08

4. Molecular Epidemiology of HIV-1 Virus in Puerto Rico: Novel Cases of HIV-1 Subtype C, D, and CRF-24BG;AIDS Research and Human Retroviruses;2018-06

5. Drug resistance in B and non-B subtypes amongst subjects recently diagnosed as primary/recent or chronic HIV-infected over the period 2013–2016: Impact on susceptibility to first-line strategies including integrase strand-transfer inhibitors;Journal of Global Antimicrobial Resistance;2017-09